AzTrials
AzTrials

AgingNCT05955131

Bread Supplemented With Chilean Beans to Decrease Postprandial Glycoxidative Responses: A Pilot Intervention

A study testing Nutritional acute postprandial intervention: bread suppelmented with Chilean beans in people with Aging, run by University of Talca at 1 site in Chile.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this trial is to assess in healthy subjects between 60 and 70 years the effect of glycemic and glycoxidative postprandial responses and platelet aggregation after intake of bread supplemented with Chilean beans flour when compared with a non supplemented control. Read more about this study

Who is it for?
Ages 60 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Aging
What is being tested?
Nutritional acute postprandial intervention: bread suppelmented with Chilean beans
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteChile
Study dates
5 May 2023to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Persons between 60-70 years old.
  • Persons autonomous.
  • Persons who are willing to participate in this study and who have agreed and signed the informed consent.

Who cannot join

  • Clinical diagnosis of diabetes
  • Persons with levels of glycosylated hemoglobin (HbA1c) lhigher than 6.5
  • Clinical diagnosis and uncontrolled chronic diseases.
  • Anemia, dtermined by ferritin levels less than 15 µg/ L.
  • Oropharyngeal disorders (self-reported).
  • Persons with gastric bypass surgery.
Show all 11Show fewer
  • Celiac disease (self-reported).
  • Coagulation disorders (self-reported).
  • Use of medications that modify the glycemic response or lipid profile (acarbose, thiazolinediones, metformin, insulin, orlistat, among others).
  • Clinical diagnosis of Alzheimer's disease or sinile dementia.
  • People with pacemakers or metal subcutaneous implants.

Trial locations and contacts

1 site in 1 country.

Chile1 site
  • School of Nutrition and Dietetics

    Talca, 3460000

Other trials in Chile

About this study

Official title: Formulación de Productos de panificación Suplementados Con Harina de Porotos Nativos Chilenos Para Disminuir Respuestas glicémicas Postprandiales y agregación Plaquetaria en Personas Mayores: Un Estudio Piloto

The goal of this trial is to assess in healthy subjects between 60 and 70 years the effect of glycemic and glycoxidative postprandial responses and platelet aggregation after intake of bread supplemented with Chilean beans flour when compared with a non supplemented control. The main questions to answer are:

  • It is possible to decrease postprandial glycemic and glycoxidative responses by means of the intake of bread supplemented with Chilean beans flour when compared to the intake of a control bread non supplemented in healthy elderly persons?
  • How is affected the platelet aggregation process during postprandial state after intake of bread supplemented with Chilean beans flour, when compared to the intake of a control bread non supplemented in healthy elderly persons?
Read more

Participants will:

  • Be characterized by means of: 1) evaluation of body composition, using anthropometric techniques, bioimpedance and 2) biochemical analyses: biochemical profile, lipid profile, serum ferritin, fasting glycemia, HbA1c and insulin.
  • Arrive at fast to the laboratory and eat randomly control bread, 30% Chilean beans supplemented bread or glucose. Venous blood samples will be taken from the cubital fossa of the dominant arm at: 0, 30, 60 and 120 min postprandial, only after intake of bread control and supplemented bread. In addition, capillary blood will be taken at 0, 15, 30, 60, 90 and 120 min postprandial after intake of glucose, bread control or supplemented bread.
Read the detailed description

Screening and initial characterization:

Initial screening: General health status will be consulted, and glycemia will be measured at any time, using a hemoglucotest. If eligible (glycemia at any time less than 140 mg/dL), the subjects will be invited to participate in the initial characterization and postprandial study.

Initial characterization:

A medical and nutritional evaluation will be carried out. A medical doctor will ask the volunteers for general information about their state of health and medication consumption.

The nutritional evaluation (weight, height, waist circumference and body composition) will be carried out in the Nutritional Status Evaluation Laboratory of the School of Nutrition and Dietetics of the University of Talca.

For the bioimpedance studies, volunteers will be asked prior to the assessment to:

  • Do not drink alcohol 48 hours before the analysis.
  • Having urinated 30 minutes before the analysis.
  • Attend the laboratory on fasting, special care must be taken not to drink coffee 4 hours before the measurement.
  • When the volunteers arrive at the laboratory, they will be asked to sit on a platform barefoot and without jewelry or metals, with the least amount of clothing possible (light clothing, light overalls, and a T-shirt to have a more exact weight, they will be asked to avoid wearing jeans that day).
  • For the measurement of the waist circumference, the volunteers will be asked to lift their shirt or blouse, until their ribs or equivalent height can be seen. These measurements will be performed by a Nutritionist in an office to protect the privacy of the volunteers.
  • Clinical laboratory blood samples. Participants will be informed by telephone of the day on which blood samples will be taken, for which they will be asked to eat their last meal at 11:00 p.m. the night before the blood test. The van will pick them up at their home, 11-12 people in total. The blood sample will be taken at the Fleming Clinic.
  • Once the results are known, at least one week in advance, we will contact the volunteers by phone to make an appointment with the doctor and eat the first of four meals.

Food intake and blood sampling.

On the day of meal intake, volunteers will be asked to have their last meal at 11:00 p.m. the day before it will be presented in the laboratory. A van will pick up the volunteers between 6:30-8:00 a.m. They will be transferred to the Fleming Clinic along with 11-12 other people to the laboratory. Once in the laboratory, two types of blood samples will be taken:

  1. Capillary blood: pricking a fingertip with a sterile lancet. A nutritionist will clean the finger of the volunteers with alcohol and later they will feel a slight prick, lasting less than a second. Capillary glycemia will be measured with that blood. This procedure will be carried out at times 0, 15, 30, 45, 60, 90 and 120 min after eating bread or glucose.
  2. Venous blood: upon arrival at the laboratory (fasting) a Nurse will insert a conventional venous line in the arm. A 5 mL sample (equivalent to a teaspoon) of blood will be drawn at the following times: 0, 30, 60, and 120 min. Per day each volunteer will donate aprox. 20mL of blood, equivalent to approximately two tablespoons.

After arriving at the laboratory and taking the samples fasting (time 0), the volunteers will randomly receive one of the 2 samples of bread or glucose. If they receive glucose, only capillary blood samples will be taken.

If they receive a sample of bread, the volunteer must eat approximately 100 g (amount containing 50g of carbohydrates), (equivalent to 1 common bread) of the bread manufactured by us, along with 250 mL of water. Food intake time will be timed, and the volunteers should eat slowly but steadily. The intake time from the first bite to the last cannot exceed 10 minutes.

Conditions
Aging
Being tested
Nutritional acute postprandial intervention: Control bread, Nutritional acute postprandial intervention: bread suppelmented with Chilean beans, Nutritional acute postprandial intervention: Control glucose
Keywords
Oxidative stress, Glycoxidation, Advanced glycation end products, Aging, Bread, Antioxidants, Fiber, Platelet aggregation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nutritional acute postprandial intervention: Control breadOther

    Volunteers will arrive at fasting and blood samples (aprox. 5mL) will be obtained before (0 min) and after the intake (10 min of intake) an amount of control bread containing 50g of carbohydrates, venous blood samples for determination of insulin, methyglyoxal, 3-deoxyglucosone and platelet aggregation will be collected at 30, 60, 90 and 120 mn postprandial. In addition, capillary slood will be obtained at 0, 15, 30, 60, 90 and 120 postprandial for glycemia determination

  • Nutritional acute postprandial intervention: bread suppelmented with Chilean beansOther

    Volunteers will arrive at fasting and blood samples (aprox. 5mL) will be obtained before (0 min) and after the intake (10 min of intake) an amount of supplemented bread containing 50g of carbohydrates, venous blood samples for determination of insulin, methyglyoxal, 3-deoxyglucosone and platelet aggregation will be collected at 30, 60, 90 and 120 mn postprandial. In addition, capillary slood will be obtained at 0, 15, 30, 60, 90 and 120 postprandial for glycemia determination.

  • Nutritional acute postprandial intervention: Control glucoseOther

    Volunteers will arrive at fasting and capillary blood samples will be obtained before (0 min) and after the intake an amount of control glucose containing 50g of this monosscharide (10 min of intake), capillary slood will be also obtained at 15, 30, 60, 90 and 120 postprandial for glycemia determination.

Study groups in NCT05955131
Study groupRoleWhat they receive
Control BreadOtherSubjects will eat control bread, in an amount containing 50g of carbohydrates
Receives: Other: Nutritional acute postprandial intervention: Control bread
Bread Supplemented with Chilean BeansExperimentalSubjects will eat bread supplemented with Chilean native beans at 30% w/w, in an amount containing 50g of carbohydrates
Receives: Other: Nutritional acute postprandial intervention: bread suppelmented with Chilean beans
Glucose controlOtherSubjects will drink glucose, in an amount containing 50g of carbohydrates
Receives: Other: Nutritional acute postprandial intervention: Control glucose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the postprandial levels of methylglyoxal in plasma

    Determiantion of the change in the levels of methylglyoxal in plasma by means of pre-column derivatization and posterior separation, detection and quantification by means of high performance liquid chromatography and detection by fluorescence

    Measured: 0, 30, 60 and 120 min postprandial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2023
  2. Study start5 May 2023
  3. Primary completion30 May 2023
  4. Study completion30 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Model description
This study involves an acute nutritional intervention with crossover design, in which each volunteer will eat one out of tree meals (control bread, supplemented bread or glucose), randomly, once by week. Blood samples will be taken at 0min and 30, 60 and 120 min postprandial. The volunteers will complete their participation after the intake of the three meals, hence, their participation in the study will finish after 3 weeks.
Masking
Single blind
Who is masked
Investigator
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05955131
Sponsor's protocol ID
CIES 002
Status last verified
Jul 2023
First submitted
27 Jun 2023
Last updated
21 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This was not authorized by the Institutional Ethics Comitee

Questions about this trial

What is this clinical trial studying?

A study testing Nutritional acute postprandial intervention: bread suppelmented with Chilean beans in people with Aging, run by University of Talca at 1 site in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the postprandial levels of methylglyoxal in plasma (time frame: 0, 30, 60 and 120 min postprandial). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT05955131 | AzTrials